60 Gracechurch Street
London EC3V 0HR
|Mr. Allan John Syms||Exec. Chairman||無||無||1957|
|Prof. Dawn Coverley||Founder, Chief Scientific Officer & Non-Exec. Director||無||無||1966|
|Mr. Nigel R. Lee||Fin. Director & Exec. Director||無||無||1962|
|Mr. Morgan Williams||Head of Commercialisation for Yorkshire Cancer Research and Board Observer||無||無||無|
Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
截至 無 止，Cizzle Biotechnology Holdings Plc 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。